A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Conditions
Obesity · Overweight
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Carey Chronis MD Pediatric, Infant and Adolescent Medicine, Ventura, California, United States
Contact: Principal Investigator (Carey Chronis)Stamford Therapeutics Consortium, Stamford, Connecticut, United States
Contact: Principal Investigator (David Radin)Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta, Georgia, United States
Contact: Principal Investigator (Daniel Hsia)Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Justin Ryder)Velocity Clinical Research, Lafayette, Louisiana, United States
Contact: Principal Investigator (Jibran Atwi)MedPharmics, LLC, Gulfport, Mississippi, United States
Contact: Principal Investigator (Paul Matherne)Sundance Clinical Research, St Louis, Missouri, United States
Contact: Principal Investigator (Delores Chantal Dotson)Lucas Research, Inc., Morehead City, North Carolina, United States
Contact: Principal Investigator (Kathryn Lucas)Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Silva Arslanian)Vanderbilt Health One Hundred Oaks, Nashville, Tennessee, United States
Contact: Principal Investigator (Gitanjali Srivastava)Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston, Texas, United States
Contact: Principal Investigator (Brandon Essink)La Providence Pediatrics Clinic - Chemidox Clinical Trials, Houston, Texas, United States
Contact: Principal Investigator (Ifeyinwa Onwudiwe)Martin Diagnostic Clinic, Tomball, Texas, United States
Contact: Principal Investigator (Vicki Miller)Velocity Clinical Research, Salt Lake City, South Jordan, Utah, United States
Contact: Principal Investigator (Barbara Rizzardi)Shamir Medical Center, Beer Jacob, Israel
Contact: Principal Investigator (Marianna Rachmiel)Shaare Zedek Medical Center, Jerusalem, Israel
Contact: Principal Investigator (Floris Levy-Khademi)Sheba Medical Center, Ramat Gan, Israel
Contact: Principal Investigator (Noah Gruber)Azienda Ospedaliero Universitaria Meyer, Florence, Italy
Contact: Principal Investigator (Stefano Stagi)Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy
Contact: Principal Investigator (Ivana Rabbone)Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento, Verona, Italy
Contact: Principal Investigator (Claudio Maffeis)Saitama Medical University Hospital, Iruma-Gun, Japan
Contact: Principal Investigator (Toru Kikuchi)Isesaki Municipal Hospital, Isesaki-shi, Japan
Contact: Principal Investigator (Yoko Takano)University Hospital,Kyoto Prefectural University of Medicine, Kawaramachidori, Kamigyo-ku, Kyoto-city, Japan
Contact: Principal Investigator (Satoru Sugimoto)Tokyo Medical Center, Meguro-Ku, Japan
Contact: Principal Investigator (Masashi Miharu)Shiga General Hospital, Moriyama, Japan
Contact: Principal Investigator (Katsuyuki Matsui)Nara Prefecture General Medical Center, Nara, Japan
Contact: Principal Investigator (Sayaka Yoshida)Osaka City General Hospital, Osaka, Japan
Contact: Principal Investigator (Jun Mori)Sagaekiminami Clinic, Saga, Japan
Contact: Principal Investigator (Tateo Kuno)Shikoku Medical Center for Children and Adults, Zentsujichó, Japan
Contact: Principal Investigator (Takafumi Okada)Krakowskie Centrum Medyczne - FutureMeds, Krakow, Poland
Contact: Principal Investigator (Ewelina Malec)FutureMeds - Targowek, Warsaw, Poland
Contact: Principal Investigator (Anna Liber)Instytut Diabetologii - Warsaw, Warszewo, Poland
Contact: Principal Investigator (Ewa Pankowska)FutureMeds sp. z o. o., Wroclaw, Poland
Barnsley Hospital NHS Foundation Trust, Barnsley, United Kingdom
Contact: Principal Investigator (Rajeev Gupta)Bristol Royal Hospital for Children, Bristol, United Kingdom
Contact: Principal Investigator (Dinesh Giri)Addenbrookes Hospital, Cambridge, United Kingdom
Contact: Principal Investigator (Ken Ong)Ninewells Hospital, Dundee, United Kingdom
Contact: Principal Investigator (Nicholas Conway)Northwick Park Hospital, Harrow, United Kingdom
Contact: Principal Investigator (Nilanjana Ray)Hull Royal Infirmary, Hull, United Kingdom
Contact: Principal Investigator (Verghese Mathew)Alder Hey Children's Hospital, Liverpool, United Kingdom
Contact: Principal Investigator (Senthil Senniappan)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company